Predictors of Weight Loss in Adults with Topiramate‐Treated Epilepsy (Q44400054)

2 December 2017

title

Predictors of weight loss in adults with topiramate-treated epilepsy (English)

1 reference

2 December 2017

Predictors of Weight Loss in Adults with Topiramate‐Treated Epilepsy (English)

1 reference

23 December 2023

1 reference

23 December 2023

1 reference

23 December 2023

5

Ulf Smith

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12690085

23 December 2023

author name string

Elinor Ben-Menachem

1

1 reference

2 December 2017

Mette Axelsen

2

1 reference

2 December 2017

Else Hellebö Johanson

3

1 reference

2 December 2017

Anna Stagge

4

1 reference

2 December 2017

language of work or name

1 reference

1 April 2003

1 reference

full work available at URL

2 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1038%2Foby.2003.78

1 reference

https://onlinelibrary.wiley.com/doi/pdf/10.1038/oby.2003.78

23 December 2023

1 reference

23 December 2023

1 reference

2 December 2017

volume

11

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

556-562

1 reference

The disease burden associated with overweight and obesity

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Impact of overweight on the risk of developing common chronic diseases during a 10-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Topiramate in migraine prevention: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Open-label adjunctive topiramate in the treatment of bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Influence of topiramate in the regulation of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Effect of topiramate on body weight and body composition of osborne-mendel rats fed a high-fat diet: alterations in hormones, neuropeptide, and uncoupling-protein mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Mood stabilization and weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Topiramate and essential tremor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Topiramate as add-on treatment for patients with bipolar mania

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2003.78

31 March 2020

Identifiers

DOI

10.1038/OBY.2003.78

1 reference

2 December 2017

1 reference